OptraSCAN completes mass validation of futuristic Digital solution to fight Cancer!
The
war against Cancer just got a worthy and powerful ally in OptraSCAN's
end-to-end Digital Pathology platform and solutions that seeks to bring in
greater objectivity and precision in both cancer diagnosis and research.
The path-breaking solution has successfully
completed the mass validation of its whole slide digital scanner with the
continued support of the Government of India’s Biotechnology Industrial
Partnership Programme (BIPP) and is in keeping with the Prime Minister's call
for 'Make in India' initiatives.
The Digital Pathology platform is
the brainchild of Pune's very own bio- medical engineer and reputed
technocrat-entrepreneur, also the founder and chairman of Optra Group of
Companies Abhi Gholap, who has bagged 17 intellectual rights patents.
The maker's mission is to make digital pathology easily accessible through an
affordable and socially responsible business model for the benefit of masses.
Speaking on the occasion, Gholap
said: "India has long been recognized as IT-Services country, though
recently, Infosys founder Mr. Narayana Murthy had expressed disappointment over
the fact that India had not produced any earth-shaking invention to delight
global citizens for the last few years. Hopefully, OptraScan's latest work
should fill the lacunae. In fact, we are poised to do away with the 150 year
old Optical Microscopes and bring in much-needed objectivity in pathological
diagnosis and research. By removing subjectivity in microscopy and replacing it
with digital pathology, we hope to make cancer diagnosis more precise. Soon
multinational companies will license technology from us and this will great
benefit people on a mass scale.”
He further added: "Confined
earlier to only research applications, OptraSCAN now offers a perfect tool for
transition from conventional microscopy to digital pathology for the effective
acquisition of Whole Slide Images, viewing, sharing as well as analysis and
management of digital slides and associated metadata."
“It was indeed a great experience to work on the validation
project for OptraScan, digital pathology platform. Its small footprint makes it
useful for even small sized laboratories. The image comparison with the light
microscopy images is satisfactory and bigger advantage is facility to do Image
analysis in the same setting. Entire technical team was very enthusiastic and
proactive for whatever software or hardware refinements needed during the
validation process.
I wish all the best to the entire team and I am sure this
platform should make transition from conventional to digital pathology very
smooth for all the users.' Said Dr. Sujit Joshi, Consulting Oncopathologist-
Deenanath Mangeshkar Hospital & OncoSight Diagnostics
“I have seen OptraSCAN product in action & also have
validated whole slide scanner. The results are very encouraging and I am very
impressed with the technology & affordability which will surely be very
beneficial for easy adaption to our digital pathology needs.” Dr.Bageshri
Gogate- Prof and Head, Dept of Pathology, Incharge, Central Clinical
Laboratory, Smt. Kashibai Navale Medical College, Pune
OptraSCAN solution will enable easy
and quick transformation from conventional microscopy to digital pathology
through digitization of glass slides, assistance in analysis and interpretation
of images, real-time sharing of images for expert opinions there by aiding
early detection and treatment.
The need for innovative and cutting
edge technology to fight Cancer comes on the backdrop of a grim reality--that
it is one of India's fast growing diseases. On an average, more than 1,300
Indians succumb to the dreaded disease every day. With new cancer cases or
its incidence in India estimated to grow by 25% by 2020 (according to the
cancer registry released by the Indian Council of Medical Research),
cancer has become one of the major causes of death occurring in the
country.
This scenario will require faster
and accurate diagnosis for patient’s cases with reduced turnaround
time. The deployment of OptraSCAN’s Telepathology system would not
only allow collaboration between pathologists but also enable quick
accessibility in remote areas of the country for benefit of rural patients.
With the successful
completion of mass validation and positive response from leading Cancer
Research and Treatment Centers, established big hospitals, diagnostics
laboratories operating across India with hub & spoke model and leading
academic and research institutes, OptraSCAN is well positioned to
jump start and commercialize its end –to-end digital pathology solutions which
includes a small footprint, high and low throughput WSI scanner, an
integrated image viewer and image management system, image analysis and CARDS (
computer aided region detection system).
0 comments:
Post a Comment